Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-production of knowledge as part of a OneHealth approach to better control zoonotic diseases. | PLOS Glob Public Health | 2022 | 36962247 | PubTator, text mining | PubMed |
| Identification of NLE1/CDK1 axis as key regulator in the development and progression of non-small cell lung cancer. | Front Oncol | 2022 | 36818671 | PubTator, text mining | PubMed |
| Pre- and in-hospital delays in the use of thrombolytic therapy for patients with acute ischemic stroke in rural and urban Egypt. | Front Neurol | 2022 | 36742046 | PubTator, text mining | PubMed |
| The impact of violating the independence assumption in meta-analysis on biomarker discovery. | Front Genet | 2022 | 36726714 | PubTator, text mining | PubMed |
| [The reduced intensity conditioning of single umbilical cord blood transplantation in the treatment of Fanconi anemia: a report of three cases and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709155 | PubTator, text mining | PubMed |
| Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review. | Front Immunol | 2022 | 36703957 | PubTator, text mining | PubMed |
| Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background. | Front Endocrinol (Lausanne) | 2022 | 36686473 | PubTator, text mining | PubMed |
| SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas. | Front Genet | 2022 | 36685941 | PubTator, text mining | PubMed |
| Desorption and ablation regimes in UV-MALDI: the critical fluence. | RSC Adv | 2022 | 36683770 | PubTator, text mining | PubMed |
| Disease-Gene Networks of Skin Pigmentation Disorders and Reconstruction of Protein-Protein Interaction Networks. | Bioengineering (Basel) | 2022 | 36671585 | PubTator, text mining | PubMed |
| Is There a Relationship between Antimicrobial Use and Antibiotic Resistance of the Most Common Mastitis Pathogens in Dairy Cows? | Antibiotics (Basel) | 2022 | 36671204 | PubTator, text mining | PubMed |
| Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours. | Int J Mol Sci | 2022 | 36613762 | PubTator, text mining | PubMed |
| The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance. | Int J Mol Sci | 2022 | 36613695 | PubTator, text mining | PubMed |
| Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36612198 | PubTator, text mining | PubMed |
| Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non-small cell lung cancer. | JTCVS Open | 2022 | 36590722 | PubTator, text mining | PubMed |
| Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant. | Cold Spring Harb Mol Case Stud | 2022 | 36577523 | PubTator, text mining | PubMed |
Genome-wide distribution of histone trimethylation reveals a global impact of bisphenol A on telomeric binding proteins and histone acetyltransferase factors: a pilot study with human and in vitro data. | Clin Epigenetics | 2022 | 36572933 | PubTator, text mining | PubMed |
| The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance. | Front Immunol | 2022 | 36569948 | PubTator, text mining | PubMed |
| Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration. | Front Immunol | 2022 | 36569844 | PubTator, text mining | PubMed |
| In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations. | Genes (Basel) | 2022 | 36553489 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=33